Concepedia
Statistics
Publications
7
Citations
483
H-Index
Active since
2019
Affiliations
Bavarian Nordic (Germany)(Current)
Bavarian Nordic (United States)
Bavarian Nordic (Denmark)
Washington University in St. Louis
University of Alabama at Birmingham
Günter Silbernagl is an author at Bavarian Nordic (Germany) specializing in vaccine development, vaccination, and immunology.
Top concepts
MedicineImmunologyVaccinationVaccine DevelopmentVaccine SafetyVaccine EfficacyHivVaccinologyEpidemiologyImmunotherapy
Publications per year
2019–2024
Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox
Phillip R. Pittman, Matthew W. Hahn, HeeChoon S. Lee et al. · New England Journal of Medicine · 2019 · 251 citations · Full text
A randomized phase II trial to compare safety and immunogenicity of the MVA-BN smallpox vaccine at various doses in adults with a history of AIDS
Edgar T. Overton, Steven J. Lawrence, Jack T. Stapleton et al. · Vaccine · 2020 · 69 citations
Vaccination, Vaccine Safety, Vaccine Development +7
Safety and immunogenicity of novel modified vaccinia Ankara-vectored RSV vaccine: A randomized phase I clinical trial
Nathaly Samy, Daniela Reichhardt, Darja Schmidt et al. · Vaccine · 2020 · 59 citations
Vaccinology, Vaccination, Vaccine Development +6
One- and Two-Dose Vaccinations With Modified Vaccinia Ankara-Bavarian Nordic Induce Durable B-Cell Memory Responses Comparable to Replicating Smallpox Vaccines
Heiko Ilchmann, Nathaly Samy, Daniela Reichhardt et al. · The Journal of Infectious Diseases · 2022 · 50 citations · Full text
Reduced Respiratory Syncytial Virus Load, Symptoms, and Infections: A Human Challenge Trial of MVA-BN-RSV Vaccine
Elke Jordan, Golam Kabir, Stephanie A. Schultz et al. · The Journal of Infectious Diseases · 2023 · 30 citations · Full text
1–5 of 7